Rhumbline Advisers Jazz Pharmaceuticals PLC Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rhumbline Advisers holds 165,805 shares of JAZZ stock, worth $20.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
165,805
Previous 169,400
2.12%
Holding current value
$20.1 Million
Previous $18.1 Million
2.21%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding JAZZ
# of Institutions
513Shares Held
57.5MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$746 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$742 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$303 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$255 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$236 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.61B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...